Cachexia Pipeline Drugs and Companies 2021 – Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials – ResearchAndMarkets.com – Yahoo Finance

DUBLIN, February 18, 2022–(BUSINESS WIRE)–The "Cachexia Pipeline Drugs and Companies, 2021 – Phase, Mechanism of Action, Route, Licensing/Collaboration, Pre-clinical and Clinical Trials" report has been added to ResearchAndMarkets.com's offering.
This report presents key-decision makers with critical insights into Cachexia pipeline data. It provides complete analysis on pipeline drugs detailing Phases, route of administration, mechanism of action, licensing and collaborations, clinical trial details including pre-clinical phase and clinical trials.
The Cachexia pipeline study analyzes and monitors the development landscape with the current status of each of the pipeline drugs under development for Cachexia. In addition to recent status, overview of drugs is included in the study. Wide range of Cachexia drug related details including of company, indication, country, current status, drug alternative names, originator, orphan drug status, fast track details and others are provided.
The Cachexia pipeline study monitors the progress of new drug programs and provides analysis of phases, covering drugs from discovery to launch including discovery stage, preclinical, phase 1, phase 2, phase 3, pre-registration and other phases. The drug development stage for all Cachexia pipeline candidates is provided in the report enables you to understand timetable developments in Cachexia therapeutic area.
Details of technologies used for development of Cachexia pipeline candidates, licensing and collaboration agreements, partnership and other announcements, regulatory approval and other details are included in the Cachexia research study. Companies looking to partner with other players are also detailed in the report.
Cachexia pipeline guide details the mechanism of action of each of the drug candidate under development. Further, leading types of mechanism of action (MoA) targeted by different Cachexia companies are identified to support decision makers target the most potential drugs under development.
Further, route of administration including oral, topical, sub-cutaneous, IV, ophthalmic and others are provided to assist researchers to understand most sought and least sought route of Cachexia drug administration.
Reasons to Buy
Make better-informed decisions based on the current status of each of the pipeline drug candidate
Identify new business opportunities by evaluating the progress of the Cachexia R&D pipeline
Analyze the market and research segments based on a comprehensive analysis of Cachexia pipeline drugs and clinical trials
Identify Cachexia drug pipeline trends based on consistently delivered hands on pipeline and clinical trials information
Gain clear understanding of the Cachexia drugs through our expert coverage and in-depth analysis of drugs, companies and market trends
Check the Cachexia pipeline progress of target companies and key strategies of leading players
Gain real-time insights into the global Cachexia pipeline news, developments and insights
Key Topics Covered:
1. Table of Contents
2. Executive Summary
3. Cachexia Pipeline Snapshot, 2021
4. Cachexia Drug Profiles
5. Cachexia Clinical Trials
6. Cachexia Companies and Universities
7. Cachexia News and Deals
8. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/lny6yy
View source version on businesswire.com: https://www.businesswire.com/news/home/20220218005191/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Apparently, a new authorization for its coronavirus vaccine wasn't positive enough news for the market.
The stock market has dropped in the past four months, but many equities have been southbound for much longer than that. Let's look at two stocks that have dropped by more than 60% in the trailing-12-month period: Aurora Cannabis (NASDAQ: ACB) and Ocugen (NASDAQ: OCGN). The market reacted positively to Aurora Cannabis' latest earnings report, which was for the second quarter of its fiscal year 2022, ending on Dec. 31.
OSLO (Reuters) -Norwegian Air may order jets from Airbus in the future unless ongoing litigation with Boeing over previous aircraft cancellations is resolved in a timely fashion, the carrier's chief executive told Reuters on Friday. Norwegian, which flies a Boeing-only fleet, emerged from bankruptcy protection last May but is still locked in a dispute over the cancellation of pre-pandemic orders for 97 Boeing aircraft, which is to be decided in U.S. legal proceedings. It however managed to get a similar contract over deliveries from Airbus terminated.
(Bloomberg) — The U.S. Department of Agriculture said it’s maintaining a ban on avocados from Mexico for now, adding to concern that supply of the popular fruit may run low at some restaurants and grocery stores.Most Read from BloombergLavrov Agrees to Meet Blinken, U.S. Says: Ukraine UpdateIndia Protests Against Singapore PM’s Comments on LawmakersElon Musk Ratchets Up Trudeau Criticism With Hitler Comparison MemeMoney That Won Melania Trump NFT Came From Melania Trump WalletStocks Tumble, Bon
Canadian carriers are banking on a recent relaxation in the country's testing requirements for travel to help drive demand this year, after the government urged residents in December to avoid non-essential trips due to the virus. The December warning was accompanied by additional testing, in a blow to carriers that were counting on increased flying during the key holiday travel season after the country lifted border restrictions in August following a 16-month ban.
In a letter released by Buffett's office on Thursday, Buffett said one of his investment managers paid about $77 per share for Berkshire's 14.7 million Activision shares, acquiring about 85% of his position in October and the rest in November. Buffett also said Berkshire had "no prior knowledge" that Microsoft was working on a $68.7 billion takeover of Activision, whose franchises include "Call of Duty" and "Candy Crush," announced on Jan. 18.
The FDA is investigating consumer complaints that four babies became sick with bacteria infections after consuming products from Michigan plant
The U.S. government adds AliExpress and WeChat's e-commerce ecosystem to a list of marketplaces notorious for selling counterfeit and pirated goods.
In order to attract and retain workers in the currently tight labor market, nearly half of employers are coughing up 2022 raises that top 3%.
The success of COVID-19 vaccines based on messenger RNA (mRNA) technology from Moderna and rival Pfizer has prompted efforts to use the novel technology in other vaccines and therapeutics targeted at hard-to-treat diseases. Pfizer is also developing an mRNA-based vaccine for shingles and expects to begin clinical trials in the second half of 2022.
For investors who buy dividend stocks, that magical time of the year when your companies increase their dividend payout is like Christmas morning, or like getting a raise from your job. Industrial conglomerate 3M (NYSE: MMM) recently raised its dividend for the 63rd year in a row! 3M is an industrial conglomerate that sells thousands of products in many industries worldwide and has endured various economic booms and recessions over the years.
(Bloomberg) — A potential rollback of a Trump administration Medicare program could threaten a handful of recently listed stocks from the past two years including Clover Health Investments Corp.Most Read from BloombergLavrov Agrees to Meet Blinken, U.S. Says: Ukraine UpdateIndia Protests Against Singapore PM’s Comments on LawmakersMorgan Stanley Relationships Across Wall Street Snared in ProbeElon Musk Ratchets Up Trudeau Criticism With Hitler Comparison MemeThousands of Cars Including Audis, P
Investors questioned the durability of Sage's depression treatment on Wednesday, and Sage stock collapsed to a nearly two-year low.
The move comes against the backdrop of unionization efforts gaining momentum at large U.S. corporations, including Amazon.com Inc and Starbucks Corp. The report said employee groups at at least two Apple retail stores are backed by major national unions and are preparing to file paperwork with the National Labor Relations Board (NLRB) in the near future. At least six more locations are at less advanced stages in the unionization process, the report said, adding that Apple employees more than 65,000 retail workers.
Abbott Nutrition on Thursday announced a recall of three of its infant formulas after four babies who consumed the company's products were reported to have been hospitalized for bacterial infections.The recall is for specific lots of the company's Similac, Alimentum and EleCare formulas that were produced by its Sturgis, Mich., facility, USA Today reported.This comes as the Food and Drug Administration (FDA) advised consumers in a release on…
Data: CDC National Center for Health Statistics; Chart: Kavya Beheraj/AxiosThe average life expectancy at birth in Ohio is 76.9, according to 2019 state-by-state data released by the CDC last week.That puts the Buckeye State at No. 42 nationally and makes us the worst-ranked of the top 10 most populated U.S. states.Get market news worthy of your time with Axios Markets. Subscribe for free.Why it matters: Decreasing longevity points to underlying issues impacting Ohioans' overall health and quali
Ford Motor Co. (NYSE: F) has picked a contractor to lead the construction of twin electric vehicle battery production plants in Kentucky. Barton Malow, a Southfield, Michigan-based contractor with automotive industry expertise, will lead the project, according to Greg Christensen, electrical vehicle footprint director at Ford. It has also tapped Gray Construction, out of Lexington, Kentucky, as a partner on the project and it's looking for more local contractors as the project moves forward.
Starbucks has major growth ambitions and those ambitions are tied directly to its expansion in China. The coffee chain has accelerated its growth plans in China in recent years and has said that it wants 6,000 stores in the country of 1.5 billion people by 2022. But to be successful in China, Starbucks needs to do more than sling coffee beans.
The powder formulas were distributed across the country, and possibly exported to other countries, the FDA said.
Tech giant Amazon is hiring for the metaverse without necessarily calling attention to it. Amazon's gaming engine Lumberyard, which has struggled to make inroads into the gaming developer space, is hiring its first metaverse person. The job titled "Senior Product Manager, Technical (AWS Game Tech)" was posted on LinkedIn four days ago and is also available on the company's jobs page.

source